Genzyme Corp. v. Atrium Medical Corp.
108 F. App'x 619
CourtCourt of Appeals for the Federal Circuit
DecidedAugust 11, 2004
DocketNo. 04-1409, 04-1430
StatusPublished
This text of 108 F. App'x 619 (Genzyme Corp. v. Atrium Medical Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Genzyme Corp. v. Atrium Medical Corp., 108 F. App'x 619 (Fed. Cir. 2004).
Opinion
ORDER
Atrium Medical Corporation moves to dismiss these appeals as premature. Atrium states that Genzyme Corporation et al. does not oppose.
Accordingly,
IT IS ORDERED THAT:
(1) The appeals are dismissed as premature.
(2) Each side shall bear its own costs.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
108 F. App'x 619, Counsel Stack Legal Research, https://law.counselstack.com/opinion/genzyme-corp-v-atrium-medical-corp-cafc-2004.